Evidence map›Paper›PMID 35313327›Full record

ArticlePloS one2022

Climate solution or corporate co-optation? US and Canadian publics' views on agricultural gene editing.

Sara Nawaz, Terre Satterfield

Abstract read
In one paragraph

Article in PloS one, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Sara NawazInstitute for Resources, Environment and Sustainability, University of British Columbia, Vancouver, BC, Canada.ORCID 0000-0003-4337-1453
Terre SatterfieldInstitute for Resources, Environment and Sustainability, University of British Columbia, Vancouver, BC, Canada.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The dexterity and affordability of gene-editing technologies promise wide-ranging applications in agriculture. Aiming to take advantage of this, proponents emphasize benefits such as the climate-mitigating promises of gene editing. Critics, on the other hand, argue that gene editing will perpetuate industrialized forms of agriculture and its concomitant environmental and social problems. Across a representative sample of US and Canadian residents (n = 1478), we investigate public views and perceptions of agricultural gene editing. We advance existing survey-based studies, which tend to focus on whether knowledge, familiarity, trust, or perceptions of naturalness predict views on gene editing. Instead, we examine whether broader societal concerns about industrialized food systems-a key claim about genetic engineering launched by critics-predicts comfort with gene editing. We also explore the predictive power of views of climate change as an urgent problem, following proponent arguments. Survey results explore gene editing views in reference to specific cases (e.g., drought-tolerant wheat) and specific alternatives (e.g., versus pesticide use). We find that people critical of industrialized food systems were most likely to express overall absolute opposition to the technology, whereas those concerned with the imminence of climate change were more likely to support climate-relevant gene editing. Our findings suggest the need for further research into the conditions upon which public groups find gene editing compelling or not-namely, if applications enhance or counter industrial food systems, or offer particular climate adaptive benefits. Furthermore, we argue that attention to broader societal priorities in surveys of perceptions may help address calls for responsible research and innovation as concerns gene editing.

Indexed as

AgricultureGene EditingCanadaClimate ChangeGenetic EngineeringHumans

Identifiers

PMID35313327
PMCPMC8936474

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.